Sheets Smith Wealth Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57M Sell
2,962
-73
-2% -$33.7K 0.16% 136
2026
Q1
$1.46M Sell
3,035
-10
-0.3% -$5.12K 0.16% 131
2025
Q4
$1.71M Sell
3,045
-3
-0.1% -$1.7K 0.19% 113
2025
Q3
$1.57M Sell
3,048
-284
-9% -$124K 0.18% 119
2025
Q2
$1.05M Buy
3,332
+43
+1% +$12.9K 0.12% 159
2025
Q1
$1M Buy
3,289
+144
+5% +$48.4K 0.12% 157
2024
Q4
$1.04M Buy
3,145
+101
+3% +$34.3K 0.13% 152
2024
Q3
$1.02M Sell
3,044
-875
-22% -$332K 0.12% 157
2024
Q2
$1.61M Hold
3,919
0.19% 116
2024
Q1
$1.58M Sell
3,919
-190
-5% -$66.8K 0.18% 122
2023
Q4
$1.26M Buy
4,109
+191
+5% +$51.6K 0.18% 117
2023
Q3
$949K Buy
3,918
+88
+2% +$22.5K 0.14% 140
2023
Q2
$920K Hold
3,830
0.13% 143
2023
Q1
$720K Hold
3,830
0.11% 164
2022
Q4
$814K Hold
3,830
0.13% 152
2022
Q3
$602K Hold
3,830
0.1% 170
2022
Q2
$573K Hold
3,830
0.09% 168
2022
Q1
$627K Sell
3,830
-10
-0.3% -$1.65K 0.09% 182
2021
Q4
$836K Buy
3,840
+13
+0.3% +$2.72K 0.1% 168
2021
Q3
$724K Buy
3,827
+30
+0.8% +$5.47K 0.1% 179
2021
Q2
$671K Hold
3,797
0.09% 185
2021
Q1
$623K Hold
3,797
0.09% 177
2020
Q4
$529K Buy
3,797
+90
+2% +$11.3K 0.08% 195
2020
Q3
$414K Hold
3,707
0.07% 209
2020
Q2
$345K Hold
3,707
0.07% 190
2020
Q1
$272K Buy
3,707
+167
+5% +$14.5K 0.06% 216
2019
Q4
$298K Buy
+3,540
New +$274K 0.06% 269

Other funds holding MEDP

Sheets Smith Wealth Management's MEDP Position: Q2 2026 in Review

Sheets Smith Wealth Management reduced its Medpace (MEDP) stake by 2.4% in Q2 2026, selling an estimated $33.7K and leaving 2,962 shares worth $1.57M. The position accounts for 0.16% of the portfolio, ranked #136.

Sheets Smith Wealth Management first reported a position in MEDP in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.71M in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Sheets Smith Wealth Management held 2,962 shares of Medpace worth $1.57M as of Q2 2026.
  • Sheets Smith Wealth Management sold 73 Medpace shares in Q2 2026, an estimated $33.7K.
  • Medpace made up 0.16% of Sheets Smith Wealth Management's portfolio in Q2 2026, its #136 holding.
  • Sheets Smith Wealth Management first reported a position in Medpace in Q4 2019 and has held it in 27 quarters since.
  • Sheets Smith Wealth Management's Medpace position peaked at $1.71M in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Sheets Smith Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.